Study design
leukemia
LEUKEMIA, REMISSION, DEL
This analysis is part of a randomized clinical trial designed to evaluate the effect of supplementation with ω3-LCPUFAs on body composition in children with leukemia at the end of the remission phase and three months after supplementation, registered in the ClinicalTrials.gov database (clinicaltriasl.gov #: NCT01051154). This study was conducted in accordance with the Declaration of Helsinki, and it was approved by the National Committee of Scientific Research of Instituto Mexicano del Seguro Social (IMSS) and was conducted in the Unit of Research in the Medical Nutrition in a Pediatric Hospital in Mexico City (Approval # 2009-785-107). All parents or legal guardians of the children provided written informed consent prior to study entry.